NEW YORK, Oct. 17, 2017 -- City of London Investment Management Company Limited announced today that they will be hosting a live Webinar under Pristine Advisers and CEFNetwork regarding Emerging Markets Closed-End Funds as Legacy Products, Part II on Thursday, October 19, 2017 at 2:00 pm ET.
Presented by Barry M. Olliff, CEO and CIO, City of London Investment Management Company Limited:
- Over 50 years’ experience in the Closed-End Fund (CEF) sector
- Founder of City of London Investment Management Company Limited (1991)
- Significant experience in both London and US markets
City of London Investment Management Company Limited
- $5.2 billion in Funds Under Management (as at October 13, 2017)
- Primarily invests in Emerging Markets CEFs; $1.4 billion of exposure to US Emerging Markets CEF universe (as at October 13, 2017)
- Trades CEFs across four offices in the UK, US, Singapore and Dubai
- Introduced first “Statement on Corporate Governance and Voting Policy for Closed-End Funds” in 1999 (now in its Tenth Edition)
The presentation:
- Recent Events
- Current CEF Issues
- Aberdeen Developments and The Future of US EM CEFs
Please join us for this informative event – which also offers CFP Credit, and will be replayed as well (although you must register to receive).
The event is a must for all parties involved in the closed-end fund and/or investment community – to understand City of London’s stance on the markets, corporate governance, transparency and their views on rectifying the current state of these markets.
You may register at the following link: https://attendee.gotowebinar.com/register/8002326277330474243
Contact us with any questions, comments or concerns.
Pristine Advisers - 860-245-8519 or via email at [email protected]


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 



